Holdings of Foresite Capital Management V, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 8 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ALUMIS INC | 5,896,995 | 129.9M $ | |
| 2 | CG ONCOLOGY INC | 1,004,050 | 68M $ | |
| 3 | Disc Medicine Inc | 374,069 | 23.9M $ | |
| 4 | Hims & Hers Health Inc | 738,151 | 15.3M $ | |
| 5 | Eikon Therapeutics Inc | 1,318,983 | 14M $ | |
| 6 | Lyell Immunopharma Inc | 477,078 | 9.6M $ | |
| 7 | Nurix Therapeutics Inc | 265,000 | 4.1M $ | |
| 8 | Maze Therapeutics Inc | 25,905 | 773.3K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 8 | 265.5M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Foresite Capital Management V, LLC". https://titelia.com/en/funds/US13F1792206